Everence Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.64M Buy
83,298
+51,515
+162% +$2.39M 0.19% 91
2026
Q2
$1.36M Sell
31,783
-18,717
-37% -$1.02M 0.07% 209
2026
Q1
$3.17M Hold
50,500
– – 0.19% 101
2025
Q4
$4.82M Hold
50,500
– – 0.29% 56
2025
Q3
$4.93M Hold
50,500
– – 0.3% 55
2025
Q2
$5.42M Hold
50,500
– – 0.35% 44
2025
Q1
$5.09M Buy
50,500
+840
+2% +$84.6K 0.35% 46
2024
Q4
$4.44M Buy
49,660
+6,770
+16% +$596K 0.29% 54
2024
Q3
$3.59M Hold
42,890
– – 0.23% 80
2024
Q2
$3.08M Hold
42,890
– – 0.21% 88
2024
Q1
$2.94M Hold
42,890
– – 0.19% 99
2023
Q4
$2.48M Buy
42,890
+1,680
+4% +$89.7K 0.18% 108
2023
Q3
$2.18M Hold
41,210
– – 0.17% 113
2023
Q2
$2.12M Hold
41,210
– – 0.17% 112
2023
Q1
$2.06M Hold
41,210
– – 0.17% 115
2022
Q4
$1.91M Buy
41,210
+12,030
+41% +$521K 0.16% 116
2022
Q3
$1.13M Hold
29,180
– – 0.1% 170
2022
Q2
$1.09M Hold
29,180
– – 0.1% 175
2022
Q1
$1.29M Sell
29,180
-8,920
-23% -$387K 0.1% 169
2021
Q4
$1.62M Hold
38,100
– – 0.12% 152
2021
Q3
$1.65M Hold
38,100
– – 0.14% 133
2021
Q2
$1.63M Hold
38,100
– – 0.13% 131
2021
Q1
$1.47M Hold
38,100
– – 0.13% 133
2020
Q4
$1.37M Buy
38,100
+6,043
+19% +$218K 0.13% 130
2020
Q3
$1.22M Hold
32,057
– – 0.13% 131
2020
Q2
$1.22M Hold
32,057
– – 0.14% 122
2020
Q1
$1.05M Hold
32,057
– – 0.15% 122
2019
Q4
$1.45M Sell
32,057
-3,275
-9% -$137K 0.22% 99
2019
Q3
$1.44M Hold
35,332
– – 0.23% 97
2019
Q2
$1.52M Hold
35,332
– – 0.25% 91
2019
Q1
$1.36M Buy
35,332
+7,140
+25% +$273K 0.24% 99
2018
Q4
$996K Hold
28,192
– – 0.23% 111
2018
Q3
$1.08M Hold
28,192
– – 0.22% 122
2018
Q2
$922K Hold
28,192
– – 0.19% 141
2018
Q1
$770K Hold
28,192
– – 0.17% 154
2017
Q4
$699K Hold
28,192
– – 0.15% 170
2017
Q3
$822K Hold
28,192
– – 0.19% 149
2017
Q2
$781K Hold
28,192
– – 0.19% 147
2017
Q1
$701K Hold
28,192
– – 0.18% 153
2016
Q4
$610K Sell
28,192
-9,526
-25% -$208K 0.18% 166
2016
Q3
$898K Hold
37,718
– – 0.27% 109
2016
Q2
$881K Sell
37,718
-8,280
-18% -$179K 0.27% 108
2016
Q1
$865K Buy
45,998
+16,250
+55% +$285K 0.27% 120
2015
Q4
$549K Buy
29,748
+10,642
+56% +$191K 0.18% 159
2015
Q3
$314K Hold
19,106
– – 0.11% 225
2015
Q2
$338K Hold
19,106
– – 0.11% 220
2015
Q1
$323K Hold
19,106
– – 0.11% 226
2014
Q4
$253K Sell
19,106
-13,020
-41% -$166K 0.09% 246
2014
Q3
$407K Hold
32,126
– – 0.15% 181
2014
Q2
$410K Hold
32,126
– – 0.15% 189
2014
Q1
$434K Hold
32,126
– – 0.17% 176
2013
Q4
$386K Buy
+32,126
New +$380K 0.16% 183

Other funds holding BSX

Everence Capital Management's BSX Position: Q3 2026 in Review

Everence Capital Management increased its Boston Scientific (BSX) stake by 162% in Q3 2026, buying an estimated $2.39M and bringing the position to 83,298 shares worth $3.64M. The position accounts for 0.19% of the portfolio, ranked #91.

Everence Capital Management first reported a position in BSX in Q4 2013 and has held it in 52 quarters since. The position peaked at $5.42M in Q2 2025. 1,516 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Everence Capital Management held 83,298 shares of Boston Scientific worth $3.64M as of Q3 2026.
  • Everence Capital Management bought 51,515 Boston Scientific shares in Q3 2026, an estimated $2.39M.
  • Boston Scientific made up 0.19% of Everence Capital Management's portfolio in Q3 2026, its #91 holding.
  • Everence Capital Management first reported a position in Boston Scientific in Q4 2013 and has held it in 52 quarters since.
  • Everence Capital Management's Boston Scientific position peaked at $5.42M in Q2 2025.
  • 1,516 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.